Research programme: steroid-protein conjugates - Medexis

Drug Profile

Research programme: steroid-protein conjugates - Medexis

Alternative Names: CastBSA project; MED-C100; Steroid-protein conjugates research programme - Medexis

Latest Information Update: 04 Feb 2011

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Medexis
  • Class Albumins; Drug conjugates; Small molecules; Steroids
  • Mechanism of Action Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Cancer; Prostate cancer

Most Recent Events

  • 04 Feb 2011 No development reported - Preclinical for Cancer in Greece (unspecified route)
  • 04 Feb 2011 No development reported - Preclinical for Prostate cancer in Greece (unspecified route)
  • 07 May 2010 Pharmacodynamics data from a preclinical study in prostate cancer presented at the 101st Annual Meeting of the American Association for Cancer Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top